This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Department Of Health And Human Services (HHS)


  • HHS Advances Pathogen-Reduction Technologies for Blood Products
    Two pathogen reduction device technologies that may help reduce the risk of transmitting disease through blood product transfusions, including those diseases related to Zika virus, will advance in development with the support of the U.S. Department of Health and Human ...More
    June 20, 2016 Posted in News
  • HHS Pursues Development of Single-Dose Nasal Spray Anthrax Vaccine
    For the first time, one of the nation’s Centers for Innovation in Advanced Development and Manufacturing (CIADM) will support development of a second-generation anthrax vaccine under a task order issued by the U.S. Department of Health and Human Services’ Office ...More
    May 10, 2016 Posted in News
  • HHS Helping to Remove Hurdle in the Efforts to Develop Better Zika Diagnostics
    To speed the development of diagnostic tests for Zika virus infection, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will support the collection of blood samples from people in the continental ...More
    May 3, 2016 Posted in News
  • HHS Supports Study of Zika Virus Blood Screening Test
    The development of a test to identify whether donated blood is infected with the Zika virus is moving forward with support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and the Office of ...More
    April 22, 2016 Posted in News
  • HHS Sponsors New Broad-Spectrum Antibiotic Development
    A broad-spectrum antibiotic that could become the first of its kind to treat specific Gram-negative and Gram-positive infections as well as tularemia, a bioterrorism threat, will undergo the last steps in development with support from the U.S. Department of Health and Human ...More
    April 20, 2016 Posted in News
  • HHS Ships Blood Products to Puerto Rico in Response to Zika Outbreak
    The U.S. Department of Health and Human Services (HHS) announces that it is arranging and funding shipments of blood products from the continental United States to Puerto Rico to ensure an adequate supply of safe blood for island residents as the Commonwealth of Puerto Rico ...More
    March 8, 2016 Posted in News
  • HHS to Procure Two Inhalational Anthrax Treatments for National Supply
    To better protect public health in an anthrax attack, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) will add two types of anthrax antitoxin drugs for the Strategic National Stockpile (SNS) as ...More
    November 13, 2015 Posted in News
  • HHS Awards $2.2 Billion in Grants for HIV/AIDS Care and Medications
    Health and Human Services Secretary Sylvia M. Burwell announced today that more than $2.2 billion in Ryan White HIV/AIDS Program grants was awarded in fiscal year (FY) 2015 to cities, states and local community-based organizations. This funding supports a coordinated and ...More
    October 21, 2015 Posted in News
  • HHS Advances Development of a Novel Drug to Treat Influenza
    A monoclonal antibody therapeutic drug, a novel approach to treating patients with influenza, will advance in development with funding from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR). No ...More
    October 2, 2015 Posted in News
  • HHS Advances Development of New Monoclonal Antibody Drug for Ebola
    A novel Ebola virus disease treatment based on three monoclonal antibodies will advance in development through an agreement between the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and Regeneron ...More
    September 21, 2015 Posted in News